News Releases

Date	Title
Nov 15, 2021	Homology Medicines Reports Third Quarter 2021 Financial Results and Recent Highlights
Nov 03, 2021	Homology Medicines to Participate in Upcoming Investor Conferences
Oct 21, 2021	Homology Medicines Announces Presentations Across Gene Therapy and Gene Editing Programs, including GTx-mAb, at European Society of Gene & Cell Therapy Meeting
Oct 20, 2021	Homology Medicines Announces Presentation of Data Supporting Clinical Programs in MPS II and PKU, including Nonclinical and Patient-Focused Research, at American Society of Human Genetics Meeting
Oct 18, 2021	Homology Medicines Initiates Clinical Trial for HMI-203, a One-Time Investigational Gene Therapy Candidate for Adults with MPS II (Hunter Syndrome)
Oct 12, 2021	Homology Medicines Announces World’s First Gene Editing Clinical Trial for PKU
Aug 12, 2021	Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights
Aug 05, 2021	Homology Medicines Appoints Gene Therapy Pioneer Beverly Davidson, Ph.D., as Chair of Scientific Advisory Board
Aug 04, 2021	Homology Medicines to Participate in Upcoming Investor Conferences
May 13, 2021	Homology Medicines Announces Presentations on its Expanding Genetic Medicines Platform and Internal GMP Manufacturing at the American Society of Gene & Cell Therapy Annual Meeting